Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1793.00 | 1590.00 | 1.1277 | 1.2651 |
| SK-BR-3 | Nilotinib | 1 | uM | 4 | 1250.00 | 814.29 | 1805.00 | 1590.00 | 1.1352 | 1.2808 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1636.00 | 1590.00 | 1.0289 | 1.0600 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 1250.00 | 814.29 | 1691.00 | 1590.00 | 1.0635 | 1.1317 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1623.00 | 1590.00 | 1.0208 | 1.0430 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 1250.00 | 814.29 | 1705.00 | 1590.00 | 1.0723 | 1.1500 |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1572.00 | 1590.00 | 0.9887 | 0.9766 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1843.00 | 1590.00 | 1.1591 | 1.3305 | |
| SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1583.00 | 1590.00 | 0.9956 | 0.9909 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3473.00 | 3234.50 | 1.0737 | 1.1635 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2621.00 | 3234.50 | 0.8103 | 0.5854 | |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 2500.00 | 1726.92 | 929.00 | 3234.50 | 0.2872 | -0.4958 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3594.00 | 3234.50 | 1.1111 | 1.2469 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3143.00 | 3234.50 | 0.9717 | 0.9376 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2515.00 | 3234.50 | 0.7776 | 0.5147 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 2500.00 | 1726.92 | 2308.00 | 3234.50 | 0.7136 | 0.3776 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 1493.00 | 3234.50 | 0.4616 | -0.1485 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 2357.00 | 3234.50 | 0.7287 | 0.4100 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 4005.00 | 3234.50 | 1.2382 | 1.5324 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3989.00 | 3234.50 | 1.2333 | 1.5212 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3737.00 | 3234.50 | 1.1554 | 1.3459 |
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 2500.00 | 1726.92 | 3634.00 | 3234.50 | 1.1235 | 1.2746 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 1439.00 | 3234.50 | 0.4449 | -0.1825 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 2500.00 | 1726.92 | 1850.00 | 3234.50 | 0.5720 | 0.0790 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3324.00 | 3234.50 | 1.0277 | 1.0612 |